Avid Bioservices (CDMO) Tops Q1 EPS by 3c

Avid Bioservices (NASDAQ: CDMO) reported Q1 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits